Cardinal Health (CAH)
(Delayed Data from NYSE)
$102.91 USD
-0.30 (-0.29%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $102.90 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$102.91 USD
-0.30 (-0.29%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $102.90 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Zacks News
AMETEK (AME) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
AMETEK's (AME) first-quarter results are expected to reflect the benefits of acquisitions despite economic uncertainties.
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
by Zacks Equity Research
Cardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
Should You Buy Booking Holdings (BKNG) Ahead of Q1 Earnings?
by Zacks Equity Research
Booking Holdings' (BKNG) first-quarter 2024 results are likely to reflect strength in gross bookings, hotel room nights sold, and airline ticket units sold.
Seeking Clues to Cardinal (CAH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Cardinal (CAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Should You Consider PayPal (PYPL) Ahead of Q1 Earnings?
by Zacks Equity Research
PayPal's (PYPL) first-quarter results are expected to reflect gains from its strength in Venmo, checkout experiences and BNPL solutions.
The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp
by Zacks Equity Research
10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp are included in this Analyst Blog.
Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings
by Zacks Equity Research
Lantheus' (LNTH) first-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.
Here's What You Should Know About EBAY Ahead of Q1 Earnings
by Zacks Equity Research
EBAY's first-quarter 2024 performance will likely reflect strength across its advertising business amid softness in its active buyer base.
Garmin (GRMN) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Garmin's (GRMN) first-quarter 2024 results are likely to reflect growing momentum across Fitness, Outdoor, Marine, Aviation and Auto OEM segments.
3 Medical Products Stocks Set to Beat This Earnings Season
by Urmimala Biswas
Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cencora (COR) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Cencora's (COR) second-quarter fiscal 2024 results are likely to reflect solid performance in the U.S. Healthcare Solutions segment.
Assessing Super Micro Computer (SMCI) Ahead of Q3 Earnings
by Zacks Equity Research
Super Micro Computer's (SMCI) third-quarter fiscal 2024 performance will likely reflect strength in the Server & Storage Systems and Subsystems & Accessories segments.
ETSY Gears Up to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
ETSY's first-quarter 2024 earnings are likely to have gained from growing momentum among active buyers and active sellers.
Is Amazon (AMZN) Stock Worth Buying Ahead of Q1 Earnings?
by Zacks Equity Research
Amazon's (AMZN) first-quarter results are expected to reflect strength across its Prime program, cloud business and smart device portfolio.
Cardinal Health (CAH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Paramount Global (PARA) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Paramount Global's (PARA) first-quarter performance is expected to have been aided by steady growth in viewership, driven by strength in Paramount+ amid tepid advertiser demand.
What's in Store for NXP Semiconductors' (NXPI) Q1 Earnings?
by Zacks Equity Research
NXP Semiconductors' (NXPI) first-quarter results will likely reflect strength across Industrial & IoT and Mobile end markets. However, weakening demand in the Automotive segment may have been a concern.
Rising Demand Likely to Aid GE HealthCare's (GEHC) Q1 Earnings
by Zacks Equity Research
GE HealthCare's (GEHC) first-quarter results are expected to report strong organic revenue growth, banking on balanced segmental performance driven by consistent NPIs and growing customer demand.
What's in Store for Charter Communications (CHTR) in Q1 Earnings?
by Zacks Equity Research
Charter Communications' (CHTR) first-quarter 2024 performance is likely to have benefited from its expanding broadband network despite stiff competition and slow subscriber addition.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Ongoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings
by Zacks Equity Research
Stryker's (SYK) first-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
Cardinal Health (CAH) closed the most recent trading day at $103.37, moving +0.53% from the previous trading session.
What's in Store for STMicroelectronics (STM) in Q1 Earnings?
by Zacks Equity Research
STMicroelectronics' (STM) first-quarter results are expected to reflect strength in the automotive market. However, weakening demand across the personal electronics market is a concern.
Philips' (PHG) Zenition 30 to Boost Image-Guided Surgeries
by Zacks Equity Research
Philips (PHG) announces the FDA clearance for its Zenition 30 mobile C-arm, which is intended to aid in image-guided procedures at a relatively affordable cost.